Berri Organics is a Santa Monica-based beverage company that makes organic, plant-based electrolyte and fitness drinks under its Berri Lyte and Berri Fit lines. Founded by cancer survivor Jerome Tse, the company positions its products as clean, low-sugar alternatives to conventional sports drinks and oral rehydration solutions, using ingredients like coconut water, sweet potato, ginseng root, sea salt and maqui berries. Berri products are sold in roughly 2,000 retail stores nationwide - including Whole Foods, CVS, Target, Sprouts, Wegmans and Stop & Shop - as well as on Amazon and its own D2C site, and the company donates a portion of every sale to pediatric cancer causes.
Cheng Liu is the founder, President, and CEO of Eureka Therapeutics, Inc., a clinical-stage biopharmaceutical company based in Emeryville, California. A molecular cell biologist trained at UC Berkeley and Peking University, Liu invented a novel class of TCR mimic antibodies that allow engineered T cells to recognize intracellular tumor antigens - a major challenge in treating solid tumors. Since founding Eureka in 2006 after a decade at Chiron/Novartis, he has built a pipeline of ARTEMIS T-cell therapies targeting liver cancer, multiple myeloma, and neuroblastoma, with the company's ECT204 program earning FDA RMAT Designation in January 2026 - one of the highest-priority designations the FDA gives to regenerative medicine therapies. Eureka has raised over $168 million in total funding and holds more than 500 patents worldwide.